TGFB1 and cancer: The following immune subtypes were defined in 2018: C1 (wound healing), C2 (IFN-γ dominant), C3 (inflammatory), C4 (lymphocyte depleted), C5 (immunologically quiet), and C6 (TGF-β dominant) by analyzing > 10,000 tumors derived from 33 types of cancer (90).